Thomas John brings 30+ years of expertise and experience in information technology, and global delivery to Calpion Inc as its President & CEO.
He is an early innovator of the use of automation technology. He leads Calpion Inc., providing AI and robotic process automation driven solutions on financial functions like AP Invoice Processing, Patient e-statement automation and Patient Payment solutions on the cloud. He also leads a global team of 1000+ employees in 3 locations as the President & CEO Plutus Health Inc providing RPA powered products and Revenue Cycle Management services to healthcare organizations across 22 states. Last year, Plutus Health handled nearly $1 billion worth of medical claims from coding, billing, cash posting, and AR & denial management. He was instrumental in the spin-off of Artemis ABA Inc. as its Founder & Chairman with the vision that a comprehensive, automated, and AI-driven practice management and billing software is one of the most important needs of a growing ABA practice.
His education includes the Executive Leadership in Healthcare program at the Harvard School of Public Health and a Bachelors in Electronics from Osmania University in India.
Thomas has been a serial entrepreneur since 1998, having founded and scaled many organizations. His previous accomplishments include a successful exit through an industry acquisition of his technology venture ComCreation, which he founded and grew as a pioneering innovator in mobile application development. He was also the founding member of a Silicon Valley-based venture-funded tech company—Accellion—that built cutting-edge secure file-hosting solutions in 1998 during the early internet wave. Thomas is an innovative and enterprising technology executive with a strong track record of achievements. As an accomplished entrepreneur, leader, and strategist, he is recognized and respected by colleagues and clients for identifying technological opportunities, creating visions for change and growth, and building and leading teams to achieve exceptional results.